What is the level of liabilities of Liquidia this year?
Liquidia has a debt balance of 71.04 M USD this year.
Liquidia Liabilities 2024
Liquidia Liabilities
71.04 M USD
Ticker
LQDA
ISIN
US53635D2027
WKN
A2JRNS
In 2024, Liquidia's total liabilities amounted to 71.04 M USD, a 83.09% difference from the 38.8 M USD total liabilities in the previous year.
Liquidia Aktienanalyse
What does Liquidia do?
Liquidia Corp is a biopharmaceutical company specializing in the development of novel therapeutic products using an advanced technology called Liqutex. This technology allows for precise control over the size, shape, and surface properties of particles, enabling targeted release of active ingredients in the body. The company was founded in 2004 as a spin-off from the University of North Carolina at Chapel Hill. It has been supported by prominent investors such as PPD, Inc. and New Enterprise Associates to advance the development of new drugs. Liquidia's business model is based on creating a comprehensive product portfolio with applications in various therapeutic areas, including immunology, oncology, infectious diseases, and pulmonary hypertension. The idea is to cover a wide range of applications with the Liqutex technology to increase competitiveness in the market. To achieve this, Liquidia has formed partnerships with other companies and research institutions to advance therapeutic development. For example, it collaborates with GlaxoSmithKline on the development of vaccines for pertussis and influenza. Another important aspect of Liquidia's business model is the creation of differentiated products that address a broader range of patient needs. For instance, the company has developed a novel drug combination for the treatment of pulmonary hypertension, which exhibits better efficacy and tolerability due to its specific formulation. In addition to its focus on therapeutic applications, Liquidia has also developed a range of products for industrial use. For example, it has a specialized technology for producing high-quality nanoparticles for the electronics industry. Overall, Liquidia stands out for its versatility and innovative solutions. The company has a unique technology platform that allows it to create differentiated products for both the medical and industrial sectors. Supported by an experienced management team and prominent investors, Liquidia is pursuing a holistic growth strategy to maintain a leading role in the biotechnology industry. Liquidia Corp is a biopharmaceutical company specializing in the development of novel therapeutic products using an advanced technology called Liqutex. The company was founded in 2004 as a spin-off from the University of North Carolina at Chapel Hill and has received support from investors such as PPD, Inc. and New Enterprise Associates. Liquidia's business model focuses on creating a comprehensive product portfolio with applications in various therapeutic areas, including immunology, oncology, infectious diseases, and pulmonary hypertension. The company aims to cover a wide range of applications with its Liqutex technology to increase competitiveness in the market. To achieve this, Liquidia has formed partnerships with other companies and research institutions, such as GlaxoSmithKline, to advance therapeutic development. Additionally, Liquidia prioritizes the creation of differentiated products that address a broader range of patient needs, such as a novel drug combination for the treatment of pulmonary hypertension. In addition to therapeutic applications, Liquidia has also developed products for industrial use, such as specialized technology for producing nanoparticles for the electronics industry. Liquidia distinguishes itself through its versatility and innovative solutions, with a unique technology platform and a holistic growth strategy supported by an experienced management team and prominent investors. Liquidia ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Liquidia's Liabilities
Liquidia's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Liquidia's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Liquidia's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Liquidia's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Liquidia’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Liquidia stock
What were the liabilities of Liquidia compared to the previous year?
The liabilities of Liquidia have increased by 83.09% increased compared to the previous year.
What are the consequences of high debt for investors of Liquidia?
High liabilities can pose a risk for investors of Liquidia, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Liquidia?
Low liabilities mean that Liquidia has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Liquidia affect the company?
An increase in liabilities of Liquidia can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Liquidia affect the company?
A decrease in the liabilities of Liquidia can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Liquidia?
Some factors that can influence the liabilities of Liquidia include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Liquidia so important for investors?
The liabilities of Liquidia are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Liquidia take to modify the liabilities?
To change its liabilities, Liquidia can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Liquidia pay?
Over the past 12 months, Liquidia paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Liquidia is expected to pay a dividend of 0 USD.
What is the dividend yield of Liquidia?
The current dividend yield of Liquidia is .
When does Liquidia pay dividends?
Liquidia pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Liquidia?
Liquidia paid dividends every year for the past 0 years.
What is the dividend of Liquidia?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Liquidia located?
Liquidia is assigned to the 'Health' sector.
Wann musste ich die Aktien von Liquidia kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Liquidia from 11/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/5/2024.
When did Liquidia pay the last dividend?
The last dividend was paid out on 11/5/2024.
What was the dividend of Liquidia in the year 2023?
In the year 2023, Liquidia distributed 0 USD as dividends.
In which currency does Liquidia pay out the dividend?
The dividends of Liquidia are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Liquidia
Our stock analysis for Liquidia Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Liquidia Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
